What changed for Stroke
A plain English summary of what recently moved in the public data Voxsanity tracks for Stroke. Updated from government registries. Not medical advice.
How to read these changes: every figure on this page is the difference between two snapshots of what Voxsanity had tracked on each date. Voxsanity only began taking daily snapshots in July 2026 and is still ingesting the public registries, so a rise here is mostly our own coverage expanding rather than new research appearing. Read it as our tracked coverage growing, not as a claim about real-world research changing this fast: it overstates how much actually changed.
Comparing the two most recent snapshots, 27 July 2026 and 28 July 2026.
- Trials recruiting at Australian sites 14 to 16 (+2)
- Trials recruiting worldwide 879 to 913 (+34)
- Late-stage (Phase 3) trials 64 to 65 (+1)
- Trials on record 5,372 to 5,555 (+183)
Newly subsidised on the PBS
No medicines were newly subsidised on the PBS for Stroke in July 2026. Voxsanity tracks 3 PBS-subsidised medicines for this condition; none of them was listed for the first time this month.
Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.
Past updates
Tracking began in July 2026. Month on month changes will appear here once a second month of data has been recorded. Until then, the comparison above shows the most recent movement.
Recent trend
Weekly, most recent weeks (fills out to a monthly trend as history grows).
Recent trial results
The 30 most recent of 153 trials tracked for Stroke that have reported results to a public registry.
AI generated results summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
-
NCT05906602 · results posted 23 February 2026
According to the results reported on ClinicalTrials.gov, this trial involved 20 people who had experienced a stroke (11 in one group, 9 in the other). It used a "crossover" design, meaning participants tried both the real procedure — called ischemic conditioning, which involves briefly reducing blood flow to a limb using a cuff — and a sham (pretend) version of the same procedure, just in different orders. The trial was measuring several things related to brain and muscle function in the leg: how excitable the brain's movement-control area was, how much one side of the brain was "quieting down...
View reported results on ClinicalTrials.gov ↗ · Linked publication on PubMed ↗
-
NCT04993079 · results posted 23 January 2026
According to the results reported on ClinicalTrials.gov, this trial enrolled 45 participants, all in a single group (there was no comparison group). Thirty-nine participants completed the trial, and six did not. The trial was testing a device called Clotild®, which is a sensor-based tool designed to measure the electrical properties of a blood clot blocking a brain artery — with the goal of identifying what the clot is made of (for example, whether it contains mostly red blood cells or platelets). This kind of information could help guide stroke treatment decisions during a procedure to remove...
-
NCT04309474 · results posted 22 December 2025
According to the results reported on ClinicalTrials.gov, this trial (NCT04309474) enrolled 121 people in total — 60 in the placebo group and 61 in the elezanumab group. The trial was measuring stroke severity and functional recovery in people who had experienced a stroke. The main thing being tracked was a standard stroke severity score called the NIHSS (National Institutes of Health Stroke Scale), which runs from 0 to 42, where higher numbers indicate greater impairment. A secondary measure looked at how many participants reached a certain level of recovery on a disability scale called the Mo...
-
NCT03142841 · results posted 18 December 2025
According to the results reported on ClinicalTrials.gov, this trial enrolled 105 people in a Standard Care group and 105 people in an Intervention group (called a Problem Solving Intervention), for a total of 210 participants. The trial was measuring outcomes for **caregivers** — people who look after someone else, such as a family member with an illness. By the end of the study, 86 people in the Standard Care group and 70 in the Intervention group had completed the trial; the remaining 19 and 35 participants respectively did not finish. The trial tracked three things over roughly 9 weeks and...
View reported results on ClinicalTrials.gov ↗ · Linked publication on PubMed ↗
-
NCT02483429 · results posted 9 December 2025
According to the results reported on ClinicalTrials.gov, this trial (NCT02483429) enrolled 130 people who visited an emergency department (ED) with dizziness or balance problems — 65 in each group. One group received a new approach called VOG-guided Rapid Triage (VRT) Care, which used specialised eye-movement recordings (video-oculography, or VOG) to help guide diagnosis. The other group received the usual standard of care (SOC) that emergency departments normally provide, which could include brain scans and specialist consultations. The trial was measuring how accurately each approach identif...
View reported results on ClinicalTrials.gov ↗ · Linked publication on PubMed ↗
-
NCT06733103 · results posted 3 December 2025
According to the results reported on ClinicalTrials.gov, this trial involved 10 people in total — 5 stroke survivors and 5 carers (people who look after someone who has had a stroke). One person from each group did not complete the study, leaving 4 stroke survivors and 4 carers whose data was used. The trial was examining how acceptable a particular intervention or approach felt to participants, using in-depth interviews guided by a research tool called the Theoretical Framework of Acceptability (TFA). This framework breaks acceptability down into 7 different aspects, or "constructs," to captu...
-
NCT05469438 · results posted 2 December 2025
According to the results reported on ClinicalTrials.gov, this trial enrolled 30 participants, all of whom completed the study — none dropped out. The trial was a single-arm study, meaning everyone received the same intervention with no comparison group. It was testing whether a sensor system that tracks how a person moves (measuring things like speed and position) could accurately predict how much a stroke survivor's arm movement would recover by the end of the study, based on information collected on the very first day. The reported data shows that the trial's main measurement was something...
-
NCT01976936 · results posted 1 December 2025
According to the results reported on ClinicalTrials.gov, this trial enrolled 162 people who had experienced a stroke — 81 in a "Standard" dose group and 81 in a "High Dose" group. The trial was measuring outcomes related to statin (cholesterol-lowering) medication dosing after stroke, and tracked both potential signs of harm to the liver or muscles, and measures of neurological and functional recovery. Of those who started, 72 in the Standard group and 77 in the High Dose group completed the study. The reported data shows that when it came to the primary measure — the number of participants w...
-
NCT06029959 · results posted 8 October 2025
According to the results reported on ClinicalTrials.gov, this trial (NCT06029959) enrolled 36 participants in a single group called the "SCOUTS3 Optimization Arm." Of those, 30 participants completed the study and 6 did not finish. The trial was measuring how consistently participants used CPAP — a breathing device worn during sleep — over a three-month period that covered both their time in inpatient rehabilitation and afterwards. The reported data shows that the primary outcome measured was CPAP adherence, meaning the average number of hours per night that participants used their CPAP devic...
-
NCT05417009 · results posted 14 July 2025
According to the results reported on ClinicalTrials.gov, this trial involved 36 people in total, split into two equal groups of 18. One group received a form of stimulation (the exact type is not described in the data provided), while the other group had electrodes attached but received no stimulation — acting as a comparison group. The trial was measuring variability in blood pressure, meaning how much a person's blood pressure fluctuated over time, rather than simply what their blood pressure was at a single point. The reported data shows that for the primary measure — how much systolic blo...
View reported results on ClinicalTrials.gov ↗ · Linked publication on PubMed ↗
-
NCT05762679 · results posted 9 July 2025
According to the results reported on ClinicalTrials.gov, this trial enrolled 42 adults who had experienced a stroke and were living with shoulder pain on the affected (paretic) side of their body. Two participants did not complete the study, leaving 40 who finished. The trial was not testing a new treatment — instead, it was a measurement study looking at whether certain physical properties of shoulder muscles differed between the stroke-affected side and the unaffected side of the same person. The researchers used two types of scans: a specialised MRI technique (called T1 rho, which measures...
-
NCT05277389 · results posted 25 June 2025
According to the results reported on ClinicalTrials.gov, this trial (NCT05277389) involved 21 people who had experienced a stroke — 11 in a control group and 10 in a group called "START." The trial was measuring arm and hand movement ability, and how much people actually used their affected arm in everyday life. Two main tools were used: the Action Research Arm Test (ARAT), which scores arm and hand tasks out of 57, and the Motor Activity Log (MAL), which rates how much a person uses their arm in daily activities on a scale of 0 to 5. Not everyone finished — 10 of the 11 control participants a...
-
NCT03666533 · results posted 10 June 2025
According to the results reported on ClinicalTrials.gov, this trial (NCT03666533) looked at whether a type of mild electrical brain stimulation called tDCS (transcranial direct current stimulation) could influence walking ability in people who had experienced a stroke. Participants were split into two groups: one received active tDCS and the other received a "sham" (dummy) version that mimicked the procedure without delivering real stimulation. A total of 44 people started the trial — 21 in the active group and 23 in the sham group — and 40 completed it (19 and 21 respectively, with 2 people n...
View reported results on ClinicalTrials.gov ↗ · Linked publication on PubMed ↗
-
NCT05767437 · results posted 23 May 2025
According to the results reported on ClinicalTrials.gov, this trial involved 20 people in total, split into two groups of 10. It used a "crossover" design, meaning each group eventually received both treatments — one group did an abdominal drawing-in manoeuvre (ADIM) exercise first and then a sham (comparison) therapy, while the other group did it in the reverse order. It is worth noting that only 16 of the 20 participants completed the study — all 10 in the first group finished, while 4 people in the second group did not. The trial was measuring how each treatment related to the way participa...
View reported results on ClinicalTrials.gov ↗ · Linked publication on PubMed ↗
-
NCT05311384 · results posted 7 March 2025
According to the results reported on ClinicalTrials.gov, this trial (NCT05311384) involved a single group of 10 participants who received what the researchers called the "Keys Intervention." Seven participants completed the study, while three did not finish. The trial was measuring changes in how people used an affected arm in everyday life, and how they felt about their own ability to carry out daily activities. Two questionnaire-style tools were used to track these changes at different points — before, during, and after the intervention. The reported data shows scores from two measuring too...
View reported results on ClinicalTrials.gov ↗ · Linked publication on PubMed ↗
-
NCT05851573 · results posted 24 February 2025
According to the results reported on ClinicalTrials.gov, this trial (NCT05851573) enrolled 11 participants, all of whom completed the study with no dropouts. The trial tested a psychosocial intervention — a type of support program addressing the emotional and mental wellbeing of participants — and measured changes in depression, anxiety, mood, stress, and related symptoms before and after the intervention. The reported data shows the following changes in scores from the start of the trial to the end. For depression, as measured by the Hospital Anxiety and Depression Scale (a questionnaire sco...
-
NCT03001713 · results posted 11 February 2025
According to the results reported on ClinicalTrials.gov, this trial (NCT03001713) involved 18,578 people across two groups. Around 11,159 people were in the intervention group, which received the program straight away, and 7,419 people were in the control group, which had a delayed start. The trial was measuring changes in two estimates of cardiovascular disease (CVD) risk — that is, the calculated chance of developing heart or blood vessel disease — over one year. The reported data shows two main measurements. The first was the change in a person's estimated 10-year CVD risk (a calculation o...
View reported results on ClinicalTrials.gov ↗ · Linked publication on PubMed ↗
-
NCT02398656 · results posted 31 January 2025
According to the results reported on ClinicalTrials.gov, this trial (NCT02398656) enrolled 637 participants in each of two groups — one group received a clot-dissolving drug called tenecteplase (tNK), and the other received antiplatelet agents (medicines commonly used to help prevent blood clots from forming or growing). The trial was measuring how well participants recovered from their stroke symptoms by 90 days, using a standard scale called the modified Rankin Scale (mRS), which runs from 0 (no symptoms) to 6 (death), where lower scores mean better outcomes. Not all participants completed t...
View reported results on ClinicalTrials.gov ↗ · Linked publication on PubMed ↗
-
NCT03473223 · results posted 14 January 2025
According to the results reported on ClinicalTrials.gov, this trial (NCT03473223) enrolled just over 18,000 people in total — approximately 9,114 in the CSL112 group and 9,112 in the placebo group. The trial was measuring whether CSL112 (compared to a placebo, an inactive dummy treatment) made a difference to the number of people who experienced a major cardiovascular event — specifically cardiovascular death, heart attack (myocardial infarction), or stroke — after a recent heart attack. These three events together were called MACE (Major Adverse Cardiovascular Events). The reported data show...
View reported results on ClinicalTrials.gov ↗ · Linked publication on PubMed ↗
-
NCT05535257 · results posted 9 January 2025
According to the results reported on ClinicalTrials.gov, this trial enrolled 20 participants, all of whom completed the study with no dropouts. The trial looked at using a Sequential Compression Device (SCD) — a type of inflatable sleeve that gently squeezes the arm in a rhythmic pattern — on the upper arm and forearm. The study was measuring whether people could tolerate wearing the sleeve, whether it caused any pain, and a number of other observations including arm colour, swelling, arm strength, and sensation. The reported data shows that all 20 participants answered "yes" when asked wheth...
-
NCT04302493 · results posted 20 December 2024
According to the results reported on ClinicalTrials.gov, this trial involved 30 stroke survivors who were split into two groups: 16 people took part in a Mindfulness Based Stress Reduction (MBSR) programme, and 14 took part in a Stroke Support Group (SSG). By the end of the study, 14 people in the MBSR group and all 14 in the SSG group had completed the trial. The trial was measuring four things: thinking and memory ability, brain activity patterns, quality of life, and symptoms of depression — all assessed at one month and six months into the study. The reported data shows the following numb...
View reported results on ClinicalTrials.gov ↗ · Linked publication on PubMed ↗
-
NCT05643573 · results posted 9 December 2024
According to the results reported on ClinicalTrials.gov, this trial compared two blood-thinning medicines — asundexian (a newer investigational drug) and apixaban (an already-approved medicine) — in people with an irregular heart rhythm called atrial fibrillation, which can raise the risk of stroke. The trial enrolled 7,383 people in the asundexian group and 7,374 in the apixaban group, making it a large study. The main things being measured were: how many people experienced a stroke or a clot travelling to another part of the body (called systemic embolism), how many experienced a serious ble...
-
NCT04882215 · results posted 14 November 2024
According to the results reported on ClinicalTrials.gov, this trial (NCT04882215) looked at a working memory training programme and enrolled 14 participants into the Adaptive Training group. No participants were recorded in the Non-Adaptive Training group. The trial was primarily a feasibility study — meaning it was designed to find out whether running a larger trial would be practical — by tracking things like how easy it was to recruit people, how many dropped out, and how well participants stuck to the programme. It also gathered participants' feedback on the experience. The reported data...
View reported results on ClinicalTrials.gov ↗ · Linked publication on PubMed ↗
-
NCT04571099 · results posted 2 October 2024
According to the results reported on ClinicalTrials.gov, this trial enrolled 28 participants in total, divided into three groups based on their type of stroke: 3 people had an ischaemic stroke (a blockage-type stroke) and did not receive a clot-removal procedure, 22 people had an ischaemic stroke and did receive a clot-removal procedure, and 3 people had a haemorrhagic stroke (a bleeding-type stroke). All 28 participants who started the study completed it. The trial was measuring how well a newer type of brain imaging device — a dual-layer cone-beam CT (CBCT) scanner used in procedural suites...
View reported results on ClinicalTrials.gov ↗ · Linked publication on PubMed ↗
-
NCT03263117 · results posted 5 September 2024
According to the results reported on ClinicalTrials.gov, this trial (NCT03263117) enrolled 260 people in total — 130 in a **sedation** group and 130 in a **general anaesthesia** group. The trial was looking at two different ways of keeping stroke patients comfortable and still during a procedure to remove a blood clot from the brain (a mechanical thrombectomy). The main thing the researchers measured was participants' level of disability at the end of the study, using a standard disability scale called the modified Rankin Scale (mRS), which runs from 0 (no symptoms at all) to 6 (death). Of the...
View reported results on ClinicalTrials.gov ↗ · Linked publication on PubMed ↗
-
NCT04387162 · results posted 27 August 2024
According to the results reported on ClinicalTrials.gov, this trial (NCT04387162) enrolled five people in total — three in an "Immediate" group and two in a "Delayed" group. The trial was looking at a treatment called Prism Adaptation Treatment, which involves wearing special glasses (prisms) as a way of addressing a condition called spatial neglect — a difficulty noticing things on one side of the body or environment, which can occur after a stroke or brain injury. The study used several questionnaires and assessment tools to measure things like participant satisfaction, daily living activiti...
-
NCT03876457 · results posted 15 March 2024
According to the results reported on ClinicalTrials.gov, this trial (NCT03876457) enrolled 352 people who had experienced a serious stroke. Participants were divided into two groups: 178 people received a procedure called endovascular thrombectomy (a technique to physically remove a blood clot from a brain artery) combined with standard medical management, while 174 people received standard medical management alone. The trial's main focus was measuring the level of disability or dependence participants experienced after their stroke, using a standard stroke recovery scale called the modified R...
View reported results on ClinicalTrials.gov ↗ · Linked publication on PubMed ↗
-
NCT03935425 · results posted 12 March 2024
According to the results reported on ClinicalTrials.gov, this trial involved 50 people in total, split evenly into two groups of 25 — one group used "FitMi Plus" and the other used "FitMi Basic." Both are versions of a home-based device designed to support arm and hand movement after stroke or similar conditions. The trial was measuring changes in how well participants could use their affected arm in everyday activities, as well as changes in the physical capability of that arm. Of the 50 who started, 48 completed the study — one person in each group did not finish. The reported data shows th...
-
NCT04550039 · results posted 1 March 2024
According to the results reported on ClinicalTrials.gov, this trial (NCT04550039) enrolled 14 participants in total — 7 in a group that used a body-weight-supported treadmill for walking training, and 7 in a group that used a powered robotic exoskeleton called the EksoNR. Five participants in each group completed the trial, with two in each group not finishing. The trial was designed to measure changes in "lateropulsion" — a condition where a person pushes or leans strongly to one side after a stroke, making balance and walking difficult. It used a range of standardised tests to track changes...
-
NCT04363944 · results posted 23 January 2024
According to the results reported on ClinicalTrials.gov, this trial (NCT04363944) looked at a smartphone-based home rehabilitation program called mRehab, designed for people working on upper limb (arm and hand) movement. A total of 19 people were enrolled — 18 in the main group using mRehab at home, and 1 in a separate group who completed all activities using both arms. Of those, 16 people in the main group and the 1 person in the other group finished the study. The trial measured things like how many repetitions of each exercise participants completed, how long each activity took, and how smo...
View reported results on ClinicalTrials.gov ↗ · Linked publication on PubMed ↗
See all 153 reported results for Stroke
These are the results as reported to the registry, not medical advice. Verify independently with the trial site and discuss what they mean for you with your doctor.
What is coming
AI generated pipeline summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
According to NIH funding data, stroke research currently attracts a very large amount of public research funding in the United States, and this level of investment has remained broadly steady year on year. For patients, this suggests that stroke is a well-established research priority that continues to attract sustained scientific attention. A stable and substantial funding base generally means re...
Not medical advice. Voxsanity republishes public government health data in plain English. These figures describe research and registry activity, not the suitability of any treatment for any person. Trial status can change; always verify current status directly with the trial site and confirm Australian availability with your doctor.